Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / T•••••••••

A•••••• Capital Partners Completes Acquisition of T•••••••••

Platform acquisitionclosedannounced Nov 3, 2025closed Nov 3, 2025Fact
What happened
Target
T•••••••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
healthcare / healthcare, pharma
Target location
IL, US
Seller kind
Corporate parent
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
8 named
Buy side
  • M•••••• T•••••Deal partnerconfirmed
    ““We are delighted to work alongside the entire T••••••••• team as they enter this next chapter of growth, staying true to the mission of addressing cold chain challenges that improve lives,” said M•••••• T•••••, a Principal of A••••••.”
  • G••••• A••Deal partnerconfirmed
    ““T•••••••••’s leadership in cold chain solutions aligns with A••••••’s focus on partnering with and helping to build businesses that deliver innovation and lasting value,” said G••••• A••, an Operating Partner of A••••••.”
  • A•••••• C•••••• M••••••••• L•Sponsorconfirmed
    “A•••••• Capital Partners (“A••••••”), a leading private equity investment firm that specializes in building market-leading industrial growth and healthcare companies, today announced it has completed the acquisition of T••••••••• from S••••• P••••••• C•••••• (“S•••••”) (NYSE: SON).”
Sell side
  • S••••• P••••••• C••••••Sellerconfirmed
    “A•••••• Capital Partners (“A••••••”), a leading private equity investment firm that specializes in building market-leading industrial growth and healthcare companies, today announced it has completed the acquisition of T••••••••• from S••••• P••••••• C•••••• (“S•••••”) (NYSE: SON).”
Advisory side
  • R•••••• J•••• L•••Financial adviserconfirmed
    “R•••••• J•••• acted as lead financial advisor to A•••••• and Kirkland & Ellis LLP served as legal counsel to A••••••.”
  • M••••• S•••••• • C•• L••Financial adviserconfirmed
    “M••••• S•••••• • C•• L•• acted as financial advisor to S••••• and Freshfields LLP served as legal counsel to S•••••.”
Side not stated
  • J•• L•••••••Managementconfirmed
    ““This strategic partnership with A•••••• will further accelerate T•••••••••’s growth, enabling us to continue to advance our technology and product portfolio to meet the evolving needs of our global customer base,” said J•• L•••••••, CEO of T•••••••••.”
  • T•••••••••Targetconfirmed
    “A•••••• Capital Partners (“A••••••”), a leading private equity investment firm that specializes in building market-leading industrial growth and healthcare companies, today announced it has completed the acquisition of T••••••••• from S••••• P••••••• C•••••• (“S•••••”) (NYSE: SON).”
Evidence
“A•••••• Capital Partners (“A••••••”), a leading private equity investment firm that specializes in building market-leading industrial growth and healthcare companies, today announced it has completed the acquisition of T••••••••• from S••••• P••••••• C•••••• (“S•••••”) (NYSE: SON).”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 14, 2026